Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) has received a new FDA 510(k) clearance for its Microdacyn Wound Irrigation Solution, expanding its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE